Noted: CDI, which was co-founded by stem cell pioneer and University of Wisconsin-Madison professor James Thomson, said last week it had launched a new cell line, called iCell DopaNeurons, that could aid research into neurological disorders like Parkinson?s disease and schizophrenia.